反对观点：非酒精性脂肪性肝炎纤维化患者是否应将减肥手术作为主要治疗方法？
CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?
作者信息
Newton Eric B, Pan Jason, Chung Waihong
机构信息
Gastroenterology Brown University Warren Alpert Medical School Providence Rhode Island USA.
出版信息
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):9-12. doi: 10.1002/cld.1226. eCollection 2022 Jul.
Abstract
Content available: Author Interview and Audio Recording.
摘要
提供的内容
作者访谈及音频记录。
相似文献
1
CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?反对观点：非酒精性脂肪性肝炎纤维化患者是否应将减肥手术作为主要治疗方法？
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):9-12. doi: 10.1002/cld.1226. eCollection 2022 Jul.
2
PRO: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as primary treatment?专业问题：非酒精性脂肪性肝炎纤维化患者应接受减重手术作为主要治疗方法吗？
Clin Liver Dis (Hoboken). 2022 Jul 16;20(1):5-8. doi: 10.1002/cld.1224. eCollection 2022 Jul.
3
Improvement in nonalcoholic fatty liver disease through bariatric surgery.通过减肥手术改善非酒精性脂肪性肝病
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):13-17. doi: 10.1002/cld.1229. eCollection 2022 Jul.
4
Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study.减重手术后非酒精性脂肪性肝炎的缓解：单转诊中心队列研究。
Surg Obes Relat Dis. 2024 May;20(5):482-489. doi: 10.1016/j.soard.2023.10.015. Epub 2023 Nov 7.
5
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis.减重手术和内镜减重治疗在非酒精性脂肪性肝炎中的作用
Clin Liver Dis. 2023 May;27(2):413-427. doi: 10.1016/j.cld.2023.01.009. Epub 2023 Feb 26.
6
Magnetic resonance imaging proton density fat fraction as an imaging-based biomarker of treatment response in patients with nonalcoholic steatohepatitis.磁共振成像质子密度脂肪分数作为非酒精性脂肪性肝炎患者治疗反应的基于成像的生物标志物。
Clin Liver Dis (Hoboken). 2022 Dec 12;20(6):198-201. doi: 10.1002/cld.1249. eCollection 2022 Dec.
7
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.减重手术可长期解决非酒精性脂肪性肝炎并使肝纤维化消退。
Gastroenterology. 2020 Oct;159(4):1290-1301.e5. doi: 10.1053/j.gastro.2020.06.006. Epub 2020 Jun 15.
8
Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery.接受减肥手术的重度肥胖患者的非酒精性脂肪性肝病
Arq Gastroenterol. 2013 Oct-Dec;50(4):285-9. doi: 10.1590/S0004-28032013000400009.
9
Behavioral health disorders related to nonalcoholic steatohepatitis.与非酒精性脂肪性肝炎相关的行为健康障碍。
Clin Liver Dis (Hoboken). 2022 Jul 16;20(2):43-47. doi: 10.1002/cld.1211. eCollection 2022 Aug.
10
The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.减肥手术在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的作用。
Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):797-811. doi: 10.1080/17474124.2017.1355731. Epub 2017 Jul 21.
引用本文的文献
1
NAFLD: A pretransplant and post-transplant conundrum.非酒精性脂肪性肝病：移植前和移植后的难题。
Clin Liver Dis (Hoboken). 2023 May 8;21(4):93-98. doi: 10.1097/CLD.0000000000000021. eCollection 2023 Apr.
本文引用的文献
1
Nonalcoholic steatohepatitis: global impact and clinical consequences.非酒精性脂肪性肝炎：全球影响及临床后果
Endocr Connect. 2021 Oct 7;10(10):R240-R247. doi: 10.1530/EC-21-0048.
2
Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.内镜减重与代谢治疗对非酒精性脂肪性肝病的影响：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2022 Mar;20(3):511-524.e1. doi: 10.1016/j.cgh.2021.03.017. Epub 2021 Mar 13.
3
US national trends in bariatric surgery: A decade of study.美国肥胖症手术的国家趋势：十年研究。
Surgery. 2021 Jul;170(1):13-17. doi: 10.1016/j.surg.2021.02.002. Epub 2021 Mar 11.
4
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.一项安慰剂对照试验评估皮下司美格鲁肽在非酒精性脂肪性肝炎中的疗效。
N Engl J Med. 2021 Mar 25;384(12):1113-1124. doi: 10.1056/NEJMoa2028395. Epub 2020 Nov 13.
5
Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes.饮食与胃旁路手术对糖尿病代谢功能的影响。
N Engl J Med. 2020 Aug 20;383(8):721-732. doi: 10.1056/NEJMoa2003697.
6
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.减重手术可长期解决非酒精性脂肪性肝炎并使肝纤维化消退。
Gastroenterology. 2020 Oct;159(4):1290-1301.e5. doi: 10.1053/j.gastro.2020.06.006. Epub 2020 Jun 15.
7
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
8
Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.胃内球囊放置术可显著改善非酒精性脂肪性肝炎患者的代谢和组织学状况。
Clin Gastroenterol Hepatol. 2021 Jan;19(1):146-154.e4. doi: 10.1016/j.cgh.2020.04.068. Epub 2020 Apr 30.
9
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists.肥胖与代谢外科医师协会、美国临床内分泌医师协会/美国内分泌学会、美国代谢与减重外科学会、美国肥胖医学协会和美国麻醉医师学会共同发布的《肥胖患者减重手术围手术期营养、代谢和非手术支持临床实践指南 2019 更新版》
Surg Obes Relat Dis. 2020 Feb;16(2):175-247. doi: 10.1016/j.soard.2019.10.025. Epub 2019 Oct 31.
10
Insurance Coverage Criteria for Bariatric Surgery: A Survey of Policies.肥胖症手术保险覆盖标准：政策调查。
Obes Surg. 2020 Feb;30(2):707-713. doi: 10.1007/s11695-019-04243-2.
Zotero 插件